Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squadron lateral retractor designed to maximize patient outcomes; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System designed to improve surgical efficiency without compromising accuracy. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; solanas posterior cervico/thoracic fixation system and avalon occipital plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. Further, it develops EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is based in Carlsbad, California.
IPO Year: 2006
Exchange: NASDAQ
Website: atecspine.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/1/2024 | Overweight → Equal-Weight | Morgan Stanley | |
| 7/8/2024 | $19.00 | Overweight | Barclays |
| 2/9/2024 | $26.00 | Overweight | Wells Fargo |
| 12/19/2023 | $16.00 → $18.00 | Buy | Needham |
| 10/20/2023 | $22.00 | Buy | ROTH MKM |
| 10/12/2022 | $12.00 | Buy | Jefferies |
| 9/12/2022 | $13.00 | Overweight | Morgan Stanley |
| 3/2/2022 | $22.00 → $17.00 | Overweight | Piper Sandler |
| 12/3/2021 | $12.50 | Neutral | Goldman Sachs |
| 11/5/2021 | $18.00 → $15.00 | Buy | Needham |
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences: The Stifel Healthcare Conference at the Lotte New York Palace Hotel in New York, NY, on November 18, 2024, with a fireside chat at 3:35pm ET The Jefferies London Healthcare Conference at the Waldorf Hilton in Aldwych, London, on November 20, 2024, with a fireside chat at 9:30am GT The Piper Sandler Healthcare Conference at the Lotte New York Palace Hotel in New York, NY, on December 4, 2024, with a fireside chat at 2:30pm ET The Stifel MedTech Madness West Coast Bu
Surgical revenue grew 30%; total revenue grew 27% Full-year revenue and profitability guidance increased Enhanced balance sheet flexibility with $50 million expansion of existing term loan facility Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2024, and recent corporate highlights. Third Quarter 2024 Financial Results Quarter Ended September 30, 2024 Total revenue $151 million GAAP gross margin 68% Non-GAAP gross margin 69% GAAP operating expenses $136 million Non-GAAP operating expe
Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2024 financial results on October 30, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. Indu
Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that the Company will feature its informatics-integrated spine procedures at the North American Spine Society (NASS) 29th Annual Meeting at McCormick Place in Chicago, Illinois, from September 25 to 27, 2024. "Our ambition to harness spine's most extensive collection of knowhow to march spine care forward will be prominent at NASS," said Pat Miles, Chairman and CEO. "ATEC's approach-specific technologies couple with our proprietary, workflow-integrated informatics like EOS Insight and SafeOp to help mitigate surgical variables and make spine
Surgical revenue grew 27% and drove total revenue growth of 25% to $146 million Full-year revenue and profitability guidance increased Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended June 30, 2024, and recent corporate highlights. Second Quarter 2024 Financial Results Quarter Ended June 30, 2024 Total revenues $ 146 GAAP gross margin 71 % Non-GAAP gross margin 71 % Operating expenses $ 138 Non-GAAP operating expenses $ 114 GAAP
Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences: The RBC West Coast Medical Device Bus Tour at the Estancia Hotel in La Jolla, CA, on August 14, 2024, at 2:45pm PT The Piper Sandler MedTech and Diagnostics California Bus Tour at the Ritz Carlton in Dana Point, CA, on August 21, 2024, at 10:20am PT The Morgan Stanley Global Healthcare Conference at the Marriott Marquis in New York, NY, on September 4, 2024, at 8:30am ET The Wells Fargo Healthcare Conference at the Encore Boston Harbor in Boston, MA, on Septemb
Completion of first EOS Insight-informed surgery kickstarts trajectory towards revolutionized spine care Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the commercial launch of EOS Insight, a groundbreaking, end-to-end spine surgery platform powered by standardized EOSedge™ scans and AI. With the first customer implementation complete, the EOS Insight-informed surgeries were successfully performed at OrthoIndy Hospital by David G. Schwartz, MD, and Craig McMains, MD. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240724711883
Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2024 financial results on July 31, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months.
Total revenue grew 27% to $138 million, with 30% growth in surgical revenue Adjusted EBITDA margin expanded 450 basis points Full-year revenue and adjusted EBITDA guidance increased to $601 million and $23 million, respectively Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2024, and recent corporate highlights. First Quarter 2024 Financial Results Quarter Ended March 31, 2024 Total revenue $138 million GAAP gross margin 70% Non-GAAP gross margin 71% GAAP operatin
Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences: The Bank of America Healthcare Conference at the Encore Hotel in Las Vegas, NV, on May 15, 2024, at 1:40pm PT The Barclays MedTech West Coast Bus Tour at the Fairmont Grand in Del Mar, CA, on May 20, 2024, at 8:00am PT The Wells Fargo West Coast MedTech Tour at the Lodge at Torrey Pines in La Jolla, CA, on May 30, 2024, at 11:40am PT The Jefferies Health Care Conference in New York, NY, on June 5, 2024, at 4:00pm ET The live webcasts will be accessible on AT
SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)
SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)
SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)
SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)
SC 13D - Alphatec Holdings, Inc. (0001350653) (Subject)
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
3 - Alphatec Holdings, Inc. (0001350653) (Issuer)
4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
144 - Alphatec Holdings, Inc. (0001350653) (Subject)
S-3ASR - Alphatec Holdings, Inc. (0001350653) (Filer)
10-Q - Alphatec Holdings, Inc. (0001350653) (Filer)
8-K - Alphatec Holdings, Inc. (0001350653) (Filer)
10-Q - Alphatec Holdings, Inc. (0001350653) (Filer)
8-K - Alphatec Holdings, Inc. (0001350653) (Filer)
SD - Alphatec Holdings, Inc. (0001350653) (Filer)
10-Q - Alphatec Holdings, Inc. (0001350653) (Filer)
8-K - Alphatec Holdings, Inc. (0001350653) (Filer)
ARS - Alphatec Holdings, Inc. (0001350653) (Filer)
Canaccord Genuity analyst Caitlin Cronin maintains Alphatec Holdings (NASDAQ:ATEC) with a Buy and maintains $25 price target.
Across the recent three months, 4 analysts have shared their insights on Alphatec Holdings (NASDAQ:ATEC), expressing a variety of opinions spanning from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 0 0 0 Last 30D 0 1 0 0 0 1M Ago 1 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 1 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Alphatec Holdings, presenting an average target of $18.
Morgan Stanley analyst Drew Ranieri maintains Alphatec Holdings (NASDAQ:ATEC) with a Overweight and lowers the price target from $19 to $16.
Stifel analyst Mathew Blackman maintains Alphatec Holdings (NASDAQ:ATEC) with a Buy and lowers the price target from $24 to $19.
Piper Sandler analyst Matthew O'Brien maintains Alphatec Holdings (NASDAQ:ATEC) with a Overweight and lowers the price target from $19 to $17.
Alphatec Holdings (NASDAQ:ATEC) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 7 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 4 0 0 0 0 3M Ago 2 0 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Alphatec Holdings, presenting an average target of $21.57, a high estimate of $25.00, and a low estimate of $19.00. Witnessing a positive
Needham analyst David Saxon reiterates Alphatec Holdings (NASDAQ:ATEC) with a Buy and maintains $23 price target.
Morgan Stanley downgraded Alphatec from Overweight to Equal-Weight
Barclays initiated coverage of Alphatec with a rating of Overweight and set a new price target of $19.00
Wells Fargo initiated coverage of Alphatec with a rating of Overweight and set a new price target of $26.00
Needham reiterated coverage of Alphatec with a rating of Buy and set a new price target of $18.00 from $16.00 previously
ROTH MKM initiated coverage of Alphatec with a rating of Buy and set a new price target of $22.00
Jefferies initiated coverage of Alphatec with a rating of Buy and set a new price target of $12.00
Morgan Stanley initiated coverage of Alphatec with a rating of Overweight and set a new price target of $13.00
Piper Sandler reiterated coverage of Alphatec Holdings with a rating of Overweight and set a new price target of $17.00 from $22.00 previously
Goldman Sachs initiated coverage of Alphatec Holdings with a rating of Neutral and set a new price target of $12.50
Needham reiterated coverage of Alphatec Holdings with a rating of Buy and set a new price target of $15.00 from $18.00 previously
Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2024 financial results on October 30, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. Indu
Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2024 financial results on July 31, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months.
Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter 2024 financial results on May 7, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. In
Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2023 financial results on August 3, 2023, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months.
REMI Robotic Navigation System to advance ATEC's procedural strategy by integrating navigation and robotics into spine workflow First quarter 2023 total revenue expected to grow more than 52% to over $108 million Full-year total revenue guidance raised to $450 million Reaffirms break-even adjusted EBITDA in 2023 and break-even free cash flow in 2025 Webcast today at 2:00pm PT/ 5:00pm ET Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it has acquired all assets related to the REMI Robotic Navigation System from Fusion Robotics, LLC, a privately held medical technology co
Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter financial results on May 4, 2023, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. In additi
Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report fourth quarter and fiscal year 2022 financial results on February 28, 2023, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for tw
Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2022 financial results on August 4, 2022, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. In additi
Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter 2022 financial results on May 5, 2022, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial in to the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months
Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report fourth quarter and full year 2021 financial results on March 1, 2022, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial in to the live webcast, please register via this link. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. In addition, a dia
Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales. In this role, Rooney will lead U.S. market growth and sales efforts. Rooney comes to Spineology with extensive spine sales experience, having served in Medical Device fields related to spinal implants and navigation for nearly 20 years. "The addition of Emory adds even further conviction about our clear opportunity for growth at Spineology," said Brian Snider, Chief Executive Officer at Spineology. "I have had the opportunity to work with Emory and have seen his impact leading sales teams, building new terri
Brian Snider Appointed New CEO Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today that John Booth will retire from his role as Chief Executive Officer of Spineology, effective November 10, 2023. The Board of Directors has selected Brian Snider as its next Chief Executive Officer, effective November 13, 2023. Mr. Booth will remain with Spineology through 2024, serving in an advisory role to facilitate a smooth transition. Mr. Booth will also resign from the Board of Directors, and the Board has nominated Mr. Snider as a Director. Snider joins Spineology with nearly twenty years of progressive leadership experience in the
Enhances EOS platform with automated alignment, surgical planning, patient-specific rod-bending, and intra-operative alignment reconciliation capabilities Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that EOS Catalyst will be introduced at the 2023 NASS Annual Meeting. EOS Catalyst builds on the already unprecedented functionality of the EOS imaging platform with automated alignment and surgical planning capabilities. "EOS is foundational to ATEC's mission to revolutionize spine surgery," said Pat Miles, Chairman and Chief Executive Officer. "Catalyst will be the first reflection of
Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that the Company's commitment to advancing lateral surgery will be prominent at the 2023 NASS Annual Meeting. The Company will introduce the Calibrate LTXTM lateral expandable implant system, technology designed to better achieve alignment goals with precise lordosis control and disc height restoration. "ATEC is uniquely dedicated to improving lateral surgery," said Pat Miles, Chairman and Chief Executive Officer. "The release of Calibrate LTX elevates our lateral procedural thesis by better enabling surgeons to achieve the most elusive goal
Total revenue of $117.7 to $118.5 million Total revenue growth of 31% to 32% Full-year 2023 total revenue now expected to approximate $472 million Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today select preliminary financial results for the third quarter ended September 30, 2023, and updated full-year 2023 revenue guidance ahead of investor meetings scheduled during the 2023 North American Spine Society (NASS) Annual Meeting. Preliminary Third Quarter 2023 Revenue Ranges Quarter Ended September 30, 2023 Surgical Revenue $103.3M to $103.9M EOS Revenue
Unleashing 100% spine focus to set the standard in spine care Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that the Company will feature technology designed to advance its comprehensive procedural solutions at the North American Spine Society (NASS) 38th Annual Meeting, which will be held at the Los Angeles Convention Center in California from October 18 to 21, 2023. "While others in our industry grapple with distraction, ATEC's presence at NASS 2023 will clearly demonstrate how 100% spine focus brings an unparalleled ability to revolutionize spine surgery," said Pat Miles, Chairman
CARLSBAD, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that Beth Altman, former Managing Partner at KPMG LLP San Diego, has been appointed as an independent director to the ATEC Board of Directors ("Board") and as Chair of the Audit Committee of the Board, with both appointments to be effective as of August 12, 2021. The Company also announced the resignation of Donald A. Williams as an independent director and as Chair of the Audit Committee of the Board and member of its Finance Committee, with such resignations effective as of August 11, 2021
CARLSBAD, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that Marie Meynadier, Ph.D., founder of EOS imaging, has been appointed as an independent director to the ATEC Board. With over 25 years of experience in the high tech and medical device industries, Dr. Meynadier currently sits on boards of multiple medical technology companies in Europe and North America. She founded and served as Chief Executive Officer of EOS imaging until 2018, after which she remains a director and head of the Strategic Committee. Prior to her tenure at EOS, Dr. Meynad
First quarter 2021 U.S. revenue grows approximately 50% compared to last year Full year 2021 U.S. revenue growth now expected to exceed 30% Tender offer for EOS imaging cleared by French regulatory authority J. Todd Koning appointed Chief Financial Officer CARLSBAD, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary revenue results for the first quarter ended March 31, 2021. The Company confirmed that the Autorité des marchés financiers (AMF), France’s financial markets regulator, cleared ATEC’s public tender offer f